The Latest Breaking News from Pfizer

US authorities have approved a vaccine that protects from one of the most widely circulating strains of coronavirus

It’s yet another sign that while the official pandemic state may be over, the days of COVID are far from it.

Legal restrictions on pseudoephedrine have not reduced meth use, but they have driven people with colds or allergies toward substitutes that seem to be completely ineffective.

All Americans ages 6 months and older are eligible for the new jabs, the CDC said Tuesday.

Moderna plans on investing $25 billion in research and development from 2024 through 2028.

Syphilis rates in Texas continue to climb, alarming healthcare workers who see the highest increases among pregnant people and newborns. A shortage of treatment is complicating efforts to combat it.

An updated Coronavirus booster that targets a new variant is expected to be made available in September

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

Chicago public health officials have said the CDC approval was all they needed to “begin the rollout” of the vaccine, which will be free for all city residents. “We already have the vaccine in Chicago,” Dr. Geraldine Luna, medical director for the Chicago Department of Public Health, said Monday.